Skip to main content

Casdin Private Growth Equity Fund GP, LLC

In the past year, 5 open-market purchase filings worth $14.4M and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$14.4M
5 filings
Sold
–
0 filings
Net
+$14.4M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Casdin Private Growth Equity Fund GP, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

LAB Standard Biotools Inc.

Director21 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 4, 2025 (view filing)8:59 PM ETDec 2-42 daysCasdin Partners GP, LLC and 7 othersDirector, 10% OwnerPPurchaseCommon Stock, $0.001 par value per share+350.0K$1.44+$502.6K+0.5%72.1M after3 lots
Nov 26, 2025 (view filing)4:58 PM ETNov 24-252 daysCasdin Partners GP, LLC and 7 othersDirector, 10% OwnerPPurchaseCommon Stock, $0.001 par value per share+7.70M$1.31+$10.1M+12.0%71.8M after2 lots
Nov 20, 2025 (view filing)7:45 PM ETNov 18-202 daysCasdin Partners GP, LLC and 7 othersDirector, 10% OwnerPPurchaseCommon Stock, $0.001 par value per share+1.07M$1.28+$1.37M+1.7%64.0M after3 lots
Nov 17, 2025 (view filing)6:58 PM ETNov 13-174 daysCasdin Partners GP, LLC and 7 othersDirector, 10% OwnerPPurchaseCommon Stock, $0.001 par value per share+925.0K$1.22+$1.13M+1.5%63.0M after3 lots
Nov 12, 2025 (view filing)7:46 PM ETNov 7-125 daysCasdin Partners GP, LLC and 7 othersDirector, 10% OwnerPPurchaseCommon Stock, $0.001 par value per share+1.18M$1.17+$1.38M+1.9%62.0M after4 lots
Sep 11, 2025 (view filing)9:03 PM ETSep 92 daysCasdin Partners GP, LLC and 7 othersDirector, 10% OwnerPPurchaseCommon Stock, $0.001 par value per share+100.0K$1.29+$128.9K+0.2%60.9M after
Sep 5, 2025 (view filing)7:08 PM ETSep 3-42 daysCasdin Partners GP, LLC and 7 othersDirector, 10% OwnerPPurchaseCommon Stock, $0.001 par value per share+500.0K$1.27+$635.8K+0.8%60.8M after2 lots
Aug 26, 2025 (view filing)8:46 PM ETAug 22-264 daysCasdin Partners GP, LLC and 7 othersDirector, 10% OwnerPPurchaseCommon Stock, $0.001 par value per share+525.0K$1.25+$658.8K+0.9%60.3M after3 lots
Aug 15, 2025 (view filing)9:18 PM ETAug 13-152 daysCasdin Partners GP, LLC and 7 othersDirector, 10% OwnerPPurchase+358.2K$1.24+$443.0K+0.6%59.8M after3 lots
Mar 4, 2025 (view filing)8:19 PM ETFeb 284 daysCasdin Partners GP, LLC and 8 othersDirector, 10% OwnerPPurchase+4.82M$1.07+$5.13M+8.9%58.8M after

See all 21 trades at LAB

TNYA Tenaya Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 4, 2021 (view filing)6:33 PM ETAug 31 dayCasdin Capital, LLC and 3 others10% OwnerPPurchase+850.0K$15.00+$12.8M+35.8%3.22M afterDuplicate filing

ABSI Absci Corp

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 28, 2021 (view filing)4:33 PM ETJul 262 daysCasdin Partners GP, LLC and 4 othersDirectorPPurchase+1.56M$16.00+$25.0M+30.1%6.75M afterDuplicate filing